OptimizeRx Corp
OPRX
Detailliertes Diagramm anzeigen
15.962USD
+0.072+0.46%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
296.78MMarktkapitalisierung
8728.77KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+0.46%
5 Tage
-15.00%
1 Monat
-11.71%
6 Monate
+59.78%
Seit Jahresbeginn
+228.44%
1 Jahr
+163.40%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von OptimizeRx Corp
Währung: USD Aktualisiert: 2025-11-11Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ sehr gesund. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer sehr schwachen Marktentwicklung zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
OptimizeRx Corp Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
7
Analysten
Kaufen
Aktuelles Rating
24.833
Kursziel
+50.41%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
OptimizeRx Corp Highlights
HöhepunkteRisiko
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
performance_growth_high
performance_growth_high_desc%!(EXTRA string=47.52%)
performance_growth_period
performance_growth_period_desc%!(EXTRA string=92.13M)
high_profit_growth
high_profit_growth_desc%!(EXTRA string=92.13M)
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=3678.24)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=13.52M, string=29.35%)
institutional_hold%!(EXTRA string=Chuck Royce)
institutional_hold_desc%!(EXTRA string=Chuck Royce, string=790.64K)
activity_increase
activity_increase_desc%!(EXTRA string=0.89)
OptimizeRx Corp Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
OptimizeRx Corp Informationen
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
BörsenkürzelOPRX
UnternehmenOptimizeRx Corp
CEOMr. Stephen L. (Steve) Silvestro
Websitehttps://www.optimizerx.com/
Verwandte Finanzinstrumente
-0.07%
-1.68%
-1.75%
-2.45%
+0.89%
-4.11%
+0.88%
+1.78%
-4.57%
-1.92%
+1.26%
-0.65%
+0.64%
-0.61%
-1.57%
+0.04%
-0.89%
-0.66%
+0.84%
-2.65%Beliebte Symbole
